The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling

Journal of Neuroimmunology

Volumn 149, Issue 1-2, 2004, Pages 77-83

  Kleinschnitz, C ^a   Brinkhoff, J ^a   Zelenka, M ^a   Sommer, C ^a   Stoll, G ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cytokines; Inflammation; MK 801; NMDA receptor; Peripheral nerve injury

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENETIC TRANSCRIPTION; MALE; MOUSE; NERVE DEGENERATION; NERVE LIGATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE; SIGNAL TRANSDUCTION; SPINAL GANGLION; STATISTICAL SIGNIFICANCE;

ANALYSIS OF VARIANCE; ANIMALS; CHEMOKINES; CONSTRICTION; CYTOKINES; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; NERVE CRUSH; PERIPHERAL NERVOUS SYSTEM DISEASES; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCIATIC NEUROPATHY; TIME FACTORS;

EID: 1542500972     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.12.013     Document Type: Article

References (40)

1. Aley K.O., Levine J.D. Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience. 111:2002;389-397.
2. Attal N., Jazat F., Kayser V., Guilbaud G. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy. Pain. 41:1990;235-251.
3. Basbaum A.I., Gautron M., Jazat F., Mayes M., Guilbaud G. The spectrum of fiber loss in a model of neuropathic pain in the rat: an electron microscopic study. Pain. 47:1991;359-367.
4. Bendszus M., Stoll G. Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging. J. Neurosci. 23:2003;10892-10896.
5. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in the rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;498-507.
6. Brück W. The role of macrophages in Wallerian degeneration. Brain Pathol. 7:1997;741-752.
7. Carlton S.M., Hargett G.L., Coggeshall R.E. Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin. Neurosci. Lett. 197:1995;25-28.
8. Coggeshall R.E., Carlton S.M. Ultrastructural analysis of NMDA, AMPA, and kainate receptors on unmyelinated and myelinated axons in the periphery. J. Comp. Neurol. 391:1998;78-86.
9. Davar G., Hama A., Deykin A., Vos B., Maciewicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res. 553:1991;327-330.
10. Erichsen H.K., Blackburn-Munro G. Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain. 98:2002;151-161.
11. Evans P.D., Reale V., Merzon R.M., Villegas J. N-methyl-D-aspartate (NMDA) and non-NMDA type glutamate receptors are present on squid giant axon Schwann cells. J. Exp. Biol. 157:1991;593-600.
12. George A., Schmidt C., Weishaupt A., Toyka K.V., Sommer C. Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp. Neurol. 160:1999;124-132.
13. George A., Marziniak M., Schäfers M., Toyka K.V., Sommer C. Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain. 88:2000;267-275.
14. Gillen C., Jander S., Stoll G. Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: comparison between immune-mediated demyelination and Wallerian degeneration. J. Neurosci. Res. 15:1998;489-496.
15. Griffin J.W., George R., Ho T. Macrophage systems in peripheral nerves. A review. J. Neuropathol. Exp. Neurol. 52:1993;553-560.
16. Hudspith M.J., Harrisson S., Smith G., Bountra C., Elliot P.J., Birch P.J., Hunt S.P., Munglani R. Effect of post-injury NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic pain. Brain Res. 822:1999;220-227.
17. Jander S., Schroeter M., Stoll G. Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia. J. Neuroimmunol. 22:2000;181-187.
18. Jander S., Schroeter M., Peters O., Witte O.W., Stoll G. Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain. J. Cereb. Blood Flow Metab. 21:2001;218-225.
19. La Fleur M., Underwood J.L., Rappolee D.A., Werb Z. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. 184:1996;2311-2326.
20. Leem J.W., Hwang J.H., Hwang S.J., Park H., Kim M.K., Choi Y. The role of peripheral N-methyl-D-aspartate receptors in Freund's complete adjuvant induced mechanical hyperalgesia in rats. Neurosci. Lett. 297:2001;155-158.
21. Mao J., Price D.D., Mayer D.J., Lu J., Hayes R.L. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res. 576:1992;254-262.
22. Munglani R., Hudspith M.J., Fleming B., Harrisson S., Smith G., Bountra C., Elliot P.J., Birch P.J., Hunt S.P. Effect of pre-emptive NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic pain. Brain Res. 822:1999;210-219.
23. Nesic O., Svrakic N.M., Xu G.Y., McAdoo D., Westlund K.N., Hulsebosch C.E., Ye Z., Galante A., Soteropoulos P., Tolias P., Young W., Hart R.P., Perez-Polo J.R. DNA microarray analysis of the contused spinal cord: effect of NMDA receptor inhibition. J. Neurosci. Res. 15:2002;406-423.
24. Okamoto K., Martin D.P., Schmelzer J.D., Mitsui Y., Low P.A. Pro-and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp. Neurol. 169:2001;386-391.
25. Parsons C.G. NMDA receptors as targets for drug action in neuropathic pain. Eur. J. Pharmacol. 429:2001;71-78.
26. Sommer C. Cytokines and neuropathic pain. Hansson P., Fields H., Hill R., Marchettini P. Neuropathic Pain: Pathophysiology and Treatment. 2001;37-62 IASP Press, Seattle.
27. Sommer C., Schaefers M. Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res. 784:1998;154-162.
28. Sommer C., Galbraith J.A., Heckmann H.M., Myers R.R. Pathology of experimental compression neuropathy producing hyperesthesia. J. Neuropathol. Exp. Neurol. 52:1993;223-233.
29. Sommer C., Schmidt C., George A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp. Neurol. 151:1998;138-142.
30. Sommer C., Marziniak M., Myers R.R. The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain. 74:1998;83-91.
31. Sommer C., Lindenlaub T., Teuteberg P., Schaefers M., Hartung T., Toyka K.V. Anti-TNF neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res. 12:2001;86-89.
32. Sorkin L.S., Xiao W.H., Wagner R., Myers R.R. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience. 81:1997;255-262.
33. Sotgiu M.L., Biella G. Differential effects of MK-801, a N-methyl-D-aspartate non-competitive antagonist, on the dorsal horn neuron hyperactivity and hyperexcitability in neuropathic rats. Neurosci. Lett. 283:2000;153-156.
34. Stoll G., Müller H.W. Nerve injury, axonal degeneration and neural regeneration: basic insights. Brain Pathol. 9:1999;313-325.
35. Stoll G., Griffin J.W., Li C.Y., Trapp B.D. Wallerian degeneration of the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J. Neurocytol. 18:1989;671-683.
36. Stoll G., Jander S., Myers R.R. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J. Peripher. Nerv. Syst. 7:2002;13-27.
37. Wagner R., Myers R.R. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience. 73:1996;625-629.
38. Winer J., Jung C.K., Shackel I., Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270:1999;41-49.
39. Yamamoto T., Yaksh T.L. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci. Lett. 135:1992;67-70.
40. Zhou S., Bonasera L., Carlton S.M. Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats. NeuroReport. 22:1996;895-900.